MESO Should I Buy

Buy now. Despite a short-term pullback and weakening MACD momentum, MESO still has a broadly bullish trend structure (SMA_5 > SMA_20 > SMA_200) and is supported by strong, event-driven fundamentals (rapid Ryoncil sales ramp, non-dilutive financing, and constructive FDA feedback). Options positioning is aggressively call-skewed (very low put/call ratios), reinforcing bullish sentiment. For an impatient buyer, the current level (~17.95) is close enough to nearby support (S1 ~17.02) to justify entry now rather than waiting for a perfect setup.

Price/Trend: MESO closed at 17.95 after a -3.96% regular-session drop, sitting slightly below the pivot (18.038), which signals near-term softness. However, the moving-average stack is bullish (SMA_5 > SMA_20 > SMA_200), implying the broader trend remains constructive. Momentum: MACD histogram is negative (-0.0226) and expanding lower, indicating bearish momentum in the very short term. RSI_6 at ~43 is neutral-to-soft (not oversold), suggesting there may still be room for chop/weakness before a clean bounce. Levels: Support S1 ~17.02 (then S2 ~16.39). Resistance R1 ~19.06 (then R2 ~19.69). With price at ~17.95, risk/reward is acceptable for an immediate entry if the stock holds above ~17.0; a reclaim of ~18.04 (pivot) would improve near-term tone. Pattern-based forward view (provided): ~1 week +1.04%, ~1 month +4.07% suggests a modest positive drift if supports hold.